Targeting the epigenetic regulation of antitumour immunity
Dysregulation of the epigenome drives aberrant transcriptional programmes that promote
cancer onset and progression. Although defective gene regulation often affects oncogenic …
cancer onset and progression. Although defective gene regulation often affects oncogenic …
Targeting signalling pathways and the immune microenvironment of cancer stem cells—A clinical update
JA Clara, C Monge, Y Yang, N Takebe - Nature reviews clinical …, 2020 - nature.com
Cancer stem cells (CSCs) have important roles in tumour development, relapse and
metastasis; the intrinsic self-renewal characteristics and tumorigenic properties of these cells …
metastasis; the intrinsic self-renewal characteristics and tumorigenic properties of these cells …
The lung microenvironment: an important regulator of tumour growth and metastasis
NK Altorki, GJ Markowitz, D Gao, JL Port… - Nature Reviews …, 2019 - nature.com
Lung cancer is a major global health problem, as it is the leading cause of cancer-related
deaths worldwide. Major advances in the identification of key mutational alterations have led …
deaths worldwide. Major advances in the identification of key mutational alterations have led …
EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
Prostate cancers are considered to be immunologically 'cold'tumors given the very few
patients who respond to checkpoint inhibitor (CPI) therapy. Recently, enrichment of …
patients who respond to checkpoint inhibitor (CPI) therapy. Recently, enrichment of …
Histone deacetylases (HDACs): evolution, specificity, role in transcriptional complexes, and pharmacological actionability
G Milazzo, D Mercatelli, G Di Muzio, L Triboli… - Genes, 2020 - mdpi.com
Histone deacetylases (HDACs) are evolutionary conserved enzymes which operate by
removing acetyl groups from histones and other protein regulatory factors, with functional …
removing acetyl groups from histones and other protein regulatory factors, with functional …
BET proteins as targets for anticancer treatment
A Stathis, F Bertoni - Cancer discovery, 2018 - AACR
Bromodomain and extraterminal domain (BET) proteins are epigenetic readers that regulate
gene expression and are involved in cancer pathogenesis. Over the last years, several BET …
gene expression and are involved in cancer pathogenesis. Over the last years, several BET …
Next frontier in tumor immunotherapy: macrophage-mediated immune evasion
Y Qiu, T Chen, R Hu, R Zhu, C Li, Y Ruan, X Xie… - Biomarker research, 2021 - Springer
Abstract Tumor-associated macrophages (TAMs), at the core of immunosuppressive cells
and cytokines networks, play a crucial role in tumor immune evasion. Increasing evidences …
and cytokines networks, play a crucial role in tumor immune evasion. Increasing evidences …
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma
Insufficient T cell infiltration into noninflamed tumors, such as hepatocellular carcinoma
(HCC), restricts the effectiveness of immune-checkpoint blockade (ICB) for a subset of …
(HCC), restricts the effectiveness of immune-checkpoint blockade (ICB) for a subset of …
A review of progress in histone deacetylase 6 inhibitors research: structural specificity and functional diversity
XH Zhang, Qin-Ma, HP Wu, MY Khamis… - Journal of medicinal …, 2021 - ACS Publications
Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing
histone deacetylation. Aberrant expression of HDACs is associated with various human …
histone deacetylation. Aberrant expression of HDACs is associated with various human …
In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma
Despite substantial progress in lung cancer immunotherapy, the overall response rate in
patients with KRAS-mutant lung adenocarcinoma (LUAD) remains low. Combining standard …
patients with KRAS-mutant lung adenocarcinoma (LUAD) remains low. Combining standard …